Lataa...
Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.
Four patients with salt-losing congenital adrenal hyperplasia (CAH) who had stopped mineralocorticoid therapy for several years, showed raised plasma concentrations of 17OH-progesterone and plasma renin activity, despite adequate glucoticoid therapy. One patient was able to reduce urinary sodium exc...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1979
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1545561/ https://ncbi.nlm.nih.gov/pubmed/475410 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|